1536054-05-3

Upstream product

• 87318-97-6 (2S)-1-[(4S)-2,2-dimethyl[1,3]dioxolan-4-yl]pent-4-en-2-ol 
• 1536054-01-9 tert-butyl (S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-4-en-2-yl carbonate 
• 1536054-03-1 tert-butyl (4S,6S)-6,7-dihydroxyhept-1-en-4-yl carbonate 
• 100-39-0 benzyl bromide 

Downstream Products

• 1536118-33-8 C₁₄H₂₀O₄ 
• 88981-39-9 (2S,4R)-1-(benzyloxy)-5-((R)-oxiran-2-yl)pentane-2,4-diol 
• 88981-40-2 (4S,6S)-4-((benzyloxy)methyl)-2,2-dimethyl-6-((R)-oxiran-2-ylmethyl)-1,3-dioxane 
• 1536054-10-0 (2S,5S)-1-((4S,6S)-6-(benzyloxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)-4-methylenehexan-2-ol 
• 1536054-12-2 ((2S,5S)-1-((4R,6S)-6-(benzyloxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)-4-methylenehexan-2-yloxy)(tert-butyl)dimethylsilane 
• 1536054-15-5 (2R,5R)-6-((4R,6S)-6-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((tert-butyldimethylsilyl)oxy)-2-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)hexan-3-one 

Relevant academic research and scientific papers

Asymmetric alcohol C-H allylation and syn -Crotylation: C9-C20 of tetrafibricin

The C9-C20 segment of the fibrinogen receptor inhibitor tetrafibricin was prepared in 10 steps (longest linear sequence). Ruthenium catalyzed enantioselective syn-crotylation is used to construct C9-C13. Iridium catalyzed asymmetric alcohol C-H allylation